Document is current
Any future updates will be listed below
-
Authors
Shah, Vrutangkumar V. https://orcid.org/0000-0002-8626-1089
McNames, James https://orcid.org/0000-0001-8091-3560
Mancini, Martina https://orcid.org/0000-0002-4532-3984
Carlson-Kuhta, Patricia https://orcid.org/0000-0002-5794-4155
Spain, Rebecca I. https://orcid.org/0000-0002-8316-3723
Nutt, John G. https://orcid.org/0000-0003-2759-1106
El-Gohary, Mahmoud https://orcid.org/0000-0002-2678-8823
Curtze, Carolin https://orcid.org/0000-0001-5394-4628
Horak, Fay B. https://orcid.org/0000-0001-7704-5459
-
Funding
Funding for this research was provided by:
National Institute on Aging (#1R44AG055388)
National Multiple Sclerosis Society (MB0027)
- License Information
-
More Information
Article History
Received: 29 June 2020
Accepted: 25 October 2020
First Online: 1 December 2020
Ethics approval and consent to participate
: The study was carried out in accordance with the recommendations of the Oregon Health & Science University (OHSU) institutional review board (IRB) with written informed consent from all subjects. All subjects gave written informed consent in accordance with the Declaration of Helsinki. The protocols were approved by the OHSU IRB (#15578).
: Not applicable.
: Drs. McNames, El-Gohary, and Horak have a significant financial interest in APDM Wearable Technologies, a company that may have a commercial interest in the results of this research and technology. Dr. Horak also consults with Biogen, Neuropore, Sanofi, and Takeda. Dr. Spain consults with TG therapeutics. These potential conflicts of interest have been reviewed and managed by OHSU.
